Search

Your search keyword '"Ranza, R."' showing total 21 results
Start Over Author "Ranza, R." Publisher bmj
21 results on '"Ranza, R."'

1. AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

Author

Gladman, D. D., primary, Starr, M., additional, Ranza, R., additional, Bravo Perdomo, A. M., additional, Strauss, M., additional, Shawi, M., additional, Han, C., additional, Rampakakis, E., additional, Andrew Östör, A., additional, and Mease, P. J., additional

Published
2023
Full Text
View/download PDF

2. POS0242 THE EFFECT OF ANTIMALARIALS ON THE OVERALL SAFETY AND PERSISTENCE OF TREATMENT WITH BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS

Author

Bredemeier, M., primary, Duarte, A., additional, Pinheiro, M., additional, Stadler, B., additional, Macieira, J. C., additional, Ranza, R., additional, Miranda, J., additional, Valim, V., additional, Castro, G., additional, Bertolo, M., additional, Sauma, M. D. F., additional, Fernandes, V., additional, Medeiros-Ribeiro, A. C., additional, Botelho, R., additional, Brenol, C., additional, Da Silveira DE Carvalho, H. M., additional, Studart, S., additional, Da Rocha Castelar Pinheiro, G., additional, Rocha, L., additional, De Leon de Lima, H., additional, Pereira, I., additional, Ohira Gazzeta, M., additional, Kakehasi, A., additional, Louzada, P., additional, Hayata, A. L. S., additional, Pina, F., additional, Alves Ferreira, M., additional, Balarini, L., additional, Silveira, I. G., additional, Kowalski, S., additional, Titton, D., additional, Mendonça Da Silva Chakr, R., additional, Ranzolin, A., additional, Laurindo, I., additional, and Xavier, R., additional

Published
2022
Full Text
View/download PDF

4. POS0650 THE IMPACT OF OLD AGE ON THE PERSISTENCE AND SAFETY OF TREATMENT WITH BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS

Author

Chakr, R., primary, Bredemeier, M., additional, Duarte, A., additional, Pinheiro, M., additional, Stadler, B., additional, Macieira, J. C., additional, Ranza, R., additional, Miranda, J., additional, Valim, V., additional, Castro, G., additional, Bertolo, M., additional, Sauma, M. D. F., additional, Fernandes, V., additional, Medeiros-Ribeiro, A. C., additional, Botelho, R., additional, Brenol, C., additional, Da Silveira De Carvalho, H. M., additional, Studart, S., additional, Da Rocha Castelar Pinheiro, G., additional, Rocha, L., additional, Pereira, I., additional, De Leon de Lima, H., additional, Ohira Gazzeta, M., additional, Kakehasi, A., additional, Louzada, P., additional, Hayata, A. L. S., additional, Pina, F., additional, Lupo, C., additional, Balarini, L., additional, Silveira, I., additional, Schowalski, S., additional, Titton, D., additional, Ranzolin, A., additional, Laurindo, I., additional, and Xavier, R., additional

Published
2022
Full Text
View/download PDF

5. POS0934 EFFICACY OF UPADACITINIB ON PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT DEFINED BY INVESTIGATOR ASSESSMENT AND PRO-BASED CRITERIA: RESULTS FROM TWO PHASE 3 STUDIES

Author

Baraliakos, X., primary, Ranza, R., additional, Ostor, A., additional, Ciccia, F., additional, Coates, L., additional, Rednic, S., additional, Walsh, J. A., additional, Gao, T., additional, Lertratanakul, A., additional, Song, I. H., additional, Ganz, F., additional, Douglas, K., additional, and Deodhar, A., additional

Published
2022
Full Text
View/download PDF

6. AB1173 INCIDENT CASES OF COVID-19 AND VACCINATION ADHERENCE IN A MULTICENTRIC COHORT OF INFLAMMATORY ARTHRITIS IN BRAZIL

Author

M M de Souza, S., primary, Medeiros-Ribeiro, A. C., additional, Bredemeier, M., additional, Duarte, A., additional, Pinheiro, M., additional, Stadler, B., additional, Macieira, J. C., additional, Ranza, R., additional, Miranda, J., additional, Valim, V., additional, Castro, G., additional, Bertolo, M., additional, Sauma, M. D. F., additional, Fernandes, V., additional, Botelho, R., additional, Brenol, C., additional, Da Silveira DE Carvalho, H. M., additional, Studart, S., additional, Da Rocha Castelar Pinheiro, G., additional, Rocha, L., additional, De Leon de Lima, H., additional, Pereira, I., additional, Ohira Gazzeta, M., additional, Kakehasi, A., additional, Louzada, P., additional, Hayata, A. L. S., additional, Pina, F., additional, Alves Ferreira, M., additional, Balarini, L., additional, Silveira, I. G., additional, Kowalski, S., additional, Titton, D., additional, Mendonça Da Silva Chakr, R., additional, Ranzolin, A., additional, Laurindo, I., additional, and Xavier, R., additional

Published
2022
Full Text
View/download PDF

7. AB0550 EFFICACY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND A LOW OR HIGH SWOLLEN JOINT COUNT: A SUBGROUP ANALYSIS OF 2 PHASE 3 STUDIES (SELECT-PsA 1 AND SELECT-PsA 2)

Author

Gossec, L., primary, Gladman, D. D., additional, Mcdearmon-Blondell, E., additional, Sewerin, P., additional, Ritchlin, C. T., additional, Feng, D., additional, Lertratanakul, A., additional, Ranza, R., additional, Tam, L. S., additional, Marchesoni, A., additional, Coates, L. C., additional, and Nash, P., additional

Published
2021
Full Text
View/download PDF

9. POS0676 SURVIVAL OF THE FIRST COURSE OF BIOLOGIC OR JAK INHIBITOR IN RHEUMATOID ARTHRITIS: ASSOCIATION WITH THE CHOICE OF AGENT AND CONCOMITANT CONVENTIONAL SYNTHETIC DMARDS

Author

Bredemeier, M., primary, Duarte, A., additional, Pinheiro, M., additional, Stadler, B., additional, Macieira, J. C., additional, Ranza, R., additional, Miranda, J., additional, Valim, V., additional, Castro, G., additional, Bertolo, M., additional, Sauma, M. D. F., additional, Fernandes, V., additional, Medeiros, A., additional, Botelho, R., additional, Brenol, C., additional, Negrão Gonçalo Dias, D., additional, Carvalho, H., additional, Studart, S., additional, Da Rocha Castelar Pinheiro, G., additional, Rocha, L., additional, Pereira, I., additional, Ohira Gazzeta, M., additional, Maria Kakehasi, A., additional, Louzada, P., additional, Hayata, A. L. S., additional, Pina, F., additional, Lupo, C., additional, Balarini, L., additional, Silveira, I., additional, Kowalski, S., additional, Titton, D., additional, Chakr, R., additional, Ranzolin, A., additional, Laurindo, I., additional, and Xavier, R., additional

Published
2021
Full Text
View/download PDF

11. SAT0601 Incidence of Serious Infections in Patients with Rheumatoid Arthritis and Spondyloarthritis Exposed To a-TNF Therapy. Results from Biobadabrasil Registry

Author

Ranza, R., primary, Laurindo, I., additional, Titton, D., additional, Bertolo, M., additional, Bianchi, W., additional, Brenol, C., additional, Carvalho, H., additional, Castro, G., additional, Cecconi, M., additional, Costa, I., additional, Duarte, A., additional, Fernandes, V., additional, Freire, M., additional, Louzada, P., additional, Maciera, J., additional, Miranda, J., additional, Moraes, J., additional, Pereira, I., additional, Pinheiro, G., additional, Sauma, M., additional, Stadler, B., additional, Toledo, R., additional, Valim, V., additional, Baaklini, C., additional, and Descalzo, M., additional

Published
2016
Full Text
View/download PDF

13. THU0631 Incidence of Serious Adverse Events in Patients with Rheumatoid Arthritis Exposed To Biologic Therapies. Results from Biobadabrasil Registry

Author

Ranza, R., primary, Laurindo, I., additional, Titton, D., additional, Bertolo, M., additional, Bianchi, W., additional, Brenol, C., additional, Bustamante, M., additional, Carvalho, H., additional, Castro, G., additional, Costa, I., additional, Duarte, A., additional, Fernandes, V., additional, Freire, M., additional, Louzada, P., additional, Maciera, J., additional, Miranda, J., additional, Moraes, J., additional, Pereira, I., additional, Pinheiro, G., additional, Sauma, M., additional, Stadler, B., additional, Toledo, R., additional, Valim, V., additional, Baaklini, C., additional, and Descalzo, M., additional

Published
2016
Full Text
View/download PDF

14. SAT0586 Herpes Zoster in The Brazilian Register -Biobadabrasil

Author

Carvalho, H., primary, Laurindo, I.M.M., additional, Ranza, R., additional, Titton, D., additional, Bertolo, M., additional, Bianchi, W., additional, Brenol, C., additional, Castelar, G., additional, Castro, G., additional, Costa, I., additional, Duarte, A., additional, Fernandes, V., additional, Freire, M., additional, Louzada, P., additional, Macieira, J., additional, MIranda, J., additional, Moraes, J., additional, Pereira, I., additional, Sauma, M., additional, Stadler, B., additional, Toledo, R., additional, Valim, V., additional, and Baaklini, C., additional

Published
2016
Full Text
View/download PDF

15. FRI0195 Switching from anti-TNF To Non anti-TNF Therapy Yield Better Survival in Rheumatoid Arthritis (RA): Results from Brazilian Register of Biological Agents in Rheumatic Diseases – Biobadabrasil

Author

Falcão, J., primary, Valim, V., additional, Titton, D., additional, Ranza, R., additional, Carvalho, H., additional, Bianchi, W., additional, Stadler, B., additional, Fernandes, V., additional, Louzada, P., additional, Bertolo, M., additional, Duarte, A., additional, Macieira, J., additional, Miranda, J., additional, Castelar, G., additional, Freire, M., additional, Toledo, R., additional, Moraes, J., additional, Costa, I., additional, Pereira, I., additional, Sauma, M., additional, Castro, G., additional, Brenol, C., additional, Zandonade, E., additional, Laurindo, I., additional, and Baaklini, C., additional

Published
2016
Full Text
View/download PDF

16. SAT0362 Incidence of Adverse Events in Patients with Rheumatoid Arthritis and Spondyloarthritis Exposed to Anti-Tnf Therapy. Data from the Brazilian Registry for Monitoring of Biologic Therapies in Rheumatic Diseases (Biobadabrasil)

Author

Ranza, R., primary, Laurindo, I., additional, Titton, D., additional, Barbosa, L., additional, Bertolo, M., additional, Bertaccini, J., additional, Brenol, C., additional, Carvalho, H., additional, Castro, G., additional, Cecconi, M., additional, Costa, I., additional, Duarte, A., additional, Fernandes, V., additional, Freire, M., additional, Louzada, P., additional, Macieira, J., additional, Miranda, J., additional, Pereira, I., additional, Pinheiro, G., additional, Pinheiro, M., additional, Sauma, M., additional, Silva, M., additional, Toledo, R., additional, Valin, V., additional, Vieira, W., additional, Baaklini, C., additional, and Descalzo, M., additional

Published
2015
Full Text
View/download PDF

19. AB1337 Brazilian ra patients agreement to fundamentals of treat to target (T2T) recommendations and knowledge of their disease and therapy: Preliminary results of a structured questionnaire

Author

Freitas, M.V.C., primary, Romeiro, L.D., additional, Torigoe, D.Y.Y., additional, Brenol, C.V., additional, Pereira, I.A., additional, Vasconcelos, J.T.S., additional, Mota, L.M.H., additional, Rezende-Fronza, L.S., additional, Bertolo, M.B., additional, Ranza, R., additional, Lima, R.A.C., additional, and Laurindo, I.M.M., additional

Published
2013
Full Text
View/download PDF

20. AB0524 Biological agents survival comparisons among different rheumatic disease - brazilian register of biological agents in rheumatic diseases - biobadabrasil

Author

Fafá, B., primary, Valim, V., additional, Peçanha, P., additional, Laurindo, I., additional, Ranzolin, A., additional, Hayata, A., additional, Duarte, Â., additional, Brenol, C., additional, Carvalho, H., additional, Pinheiro, G. C., additional, Silveira, I., additional, Pereira, I. A., additional, Costa, I., additional, Macieira, J., additional, Miranda, J. R., additional, Moraes, J. C., additional, Barbosa, L. S. G., additional, Bértolo, M., additional, Sauma, M., additional, Silva, M., additional, Freire, M., additional, Scheinberg, M., additional, Júnior, P. L., additional, Toledo, R., additional, Ranza, R., additional, Oliveira, S., additional, Fernandes, V., additional, Bianchi, W., additional, Titton, D., additional, and Brasil, Biobada, additional

Published
2013
Full Text
View/download PDF

21. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project).

Author

Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K, and Walsh JA

Subjects
Adult, Female, Humans, Linear Models, Male, Middle Aged, ROC Curve, Arthritis, Psoriatic diagnosis, Severity of Illness Index
Abstract

Objective: To develop new composite disease activity indices for psoriatic arthritis (PsA)., Methods: Data from routine clinic visits at multiple centres were collected in a systematic manner. Data included all domains identified as important in randomised controlled trials in PsA. Decisions to change treatment were used as surrogates for high disease activity. New indices were developed by multiple linear regression (psoriatic arthritis disease activity score: PASDAS) and empirically, utilising physician-defined cut-offs for disease activity (arithmetic mean of desirability functions: AMDF). These were compared with existing composite measures: Composite Psoriatic arthritis Disease Activity Index (CPDAI), Disease Activity for PSoriatic Arthritis (DAPSA), and Disease Activity Score for rheumatoid arthritis (DAS28)., Results: 161/503 (32%) subjects had treatment changes. Although all measures performed well, compared with existing indices, PASDAS was better able to discriminate between high and low disease activity (area under receiver operating curves (ROC)) curve with 95% CI: PASDAS 0.773 (0.723, 0.822); AMDF 0.730 (0.680, 0.780); CPDAI 0.719 (0.668, 0.770); DAPSA 0.710 (0.654, 0.766); DAS28 0.736 (0.680, 0.792). All measures were able to discriminate between disease activity states in patients with oligoarthritis, although area under the receiver operating curves (AUC) were generally smaller. In patients with severe skin disease (psoriasis area and severity index>10) both nonparametric and AUC curve statistics were nonsignificant for all measures., Conclusions: Two new composite measures to assess disease activity in PsA have been developed. Further testing in other datasets, including comparison with existing measures, is required to validate these instruments.

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results